Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-16 Purchase | 2022-09-19 08:37 am | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 30,000 | $1.557 | $46,710 | 60,000 (Direct) | View |
| 2021-09-10 Purchase | 2021-09-13 08:12 am | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 30,000 | $6.4667 | $194,000 | 30,000 (Direct) | View |
| 2020-11-10 Purchase | 2020-11-12 06:00 am | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 50,000 | $2.0144 | $100,720 | 115,834 (Indirect Direct) | View |
| 2019-09-24 Purchase(A) | 2020-03-23 7:12 pm | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 30,000 | $1.908 | $57,240 | 30,000 (Direct) | View |
| 2019-09-24 Purchase | 2019-09-26 9:17 pm | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 30,000 | $1.908 | $57,240 | 205,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-07 6:40 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 205,008 | $0 | 962,496 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:42 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 197,472 | $0 | 757,488 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:40 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 170,016 | $0 | 560,016 (Direct) | View |
| 2021-07-12 Option Award | 2021-07-12 4:16 pm | N/A 2031-07-12 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 390,000 | $0 | 390,000 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-19 9:12 pm | N/A 2031-03-16 | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 130,000 | $0 | 249,803 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 7:16 pm | N/A N/A | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 25,000 | $0 | 171,891 (Direct) | View |
| 2020-03-19 Exercise | 2020-03-23 7:16 pm | N/A 2030-03-18 | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 110,000 | $0 | 171,891 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-30 8:49 pm | 2020-01-22 2020-02-10 | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 6,891 | $0 | 211,891 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-30 8:49 pm | N/A N/A | Cidara Therapeutics Inc. | CDTX | Levine James E. Chief Financial Officer | 6,891 | $2.51 | 211,891 (Direct) | View |